APOE and Alzheimer disease: This is in line with previous evidence suggesting that APOE-ɛ4 carriers may be more vulnerable to different environmental factors, such as lifestyle and vascular risk factors [71], and also with a previous study showing that better sleep quality attenuates the effect of APOE-ɛ4 on AD incidence and neurofibrillary tangle burden [20].